Regulatory information - EU recommendations for composition of 2016/2017 seasonal influenza vaccines
EU vaccine composition advice is based on WHO recommendations
The European Medicines Agency has issued the European Union (EU) recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2016.
Trivalent vaccines for the 2016/2017 season should contain these three virus strains:
an A/California/7/2009 (H1N1)pdm09-like virus
an A/Hong Kong/4801/2014 (H3N2)-like virus
a B/Brisbane/60/2008-like virus
For quadrivalent vaccines with two influenza B viruses, a B/Phuket/3073/2013-like virus in addition to the strains mentioned above is considered appropriate.
These recommendations also apply to the manufacture of live attenuated influenza vaccines.
Click on this link for more information.